News Release Detail
February 6, 2006
Mylan Announces FDA Approval for Cyclobenzaprine Hydrochloride Tablets USP, 5 mg
Mylan Announces FDA Approval for Cyclobenzaprine Hydrochloride Tablets USP, 5 mg
This product will begin shipping immediately.
Mylan Laboratories Inc. is a leading pharmaceutical company with three principal subsidiaries, Mylan Pharmaceuticals Inc., Mylan Technologies Inc. and UDL Laboratories Inc. Mylan develops, licenses, manufactures, markets and distributes an extensive line of generic and proprietary products.
For more information about Mylan, visit http://www.mylan.com.
SOURCE Mylan Laboratories Inc. 02/06/2006 CONTACT: Patrick Fitzgerald, or Kris King, both of Mylan Laboratories Inc., +1-724-514-1800 Web site: http://www.mylan.com